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Background There is a high incidence of adverse effects from non-steroidal anti-inflammatory 
drugs (NSAIDs) in Thailand, but patients’ perceptions and knowledge of NSAID risks is unknown.  
Objective This study aims to assess patients’ perceptions and knowledge of NSAID risks and 
factors affecting them. 
Setting University hospital in North-East of Thailand 
Method A Cross-sectional study conducted over 4 months, using a self-administered questionnaire. 
Patients prescribed NSAIDs at least one month duration from orthopaedic clinic were recruited by 
using systematic random sampling.  
Main outcome measure Patients’ perceptions on NSAID risks, knowledge on risk factors, and their 
associated factors. 
Results A total of 474 questionnaires were assessed. Overall perceptions of risks was low (scoring 
below five on a 0 – 10 visual analogue scale), with risks associated with the renal system scoring 
highest. Perceived risk of gastrointestinal problems differed between patients using non-selective 
and selective NSAIDs (3.47±2.75 vs 2.06±2.98; P<0.001). Receiving side effect information from 
a health professional was associated with higher risk perception. Most patients (80%) identified 
high doses, renal disease and gastrointestinal ulcer increased risks of NSAIDs, but fewer than half 
recognized that use in the elderly, multiple NSAID use, drinking, hypertension and cardiovascular 
disease also increased risk of adverse events. Having underlying diseases and receiving side effect 
information were associated with 1.6-2.0 fold increased knowledge of NSAID risks. 
 
Conclusion Perceptions and knowledge concerning NSAID risks was generally low in Thai 
patients, but higher in those who had received side effect information. Risk-related information 
should be widely provided, especially in high-risk patients. 
 
Impact of findings on practice 
 Lack of awareness of risk of NSAIDs among Thai patients may lead to inappropriate use 
of these medicines, therefore health professionals should provide more information about 
their risks. 
 Older patients, those with low educational level and those who had not been given any 
side effect information had poorest perception and knowledge about NSAID risk, 
therefore these groups should be specifically targeted. 










Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and effective for pain and 
inflammation, but carry a high risk of side effects [1]. Despite this, they are frequently prescribed 
to patients with underlying factors increasing risk, such as the elderly, and those with co-
morbidities or multiple drug use [2].  Moreover studies in a range of countries suggest that patients 
have little awareness of the risk of these medicines [3-10]. In one study only a third of Turkish 
patients with osteoarthritis were aware of side effects of NSAIDs, with 85.4% of these identifying 
only gastrointestinal risks [5]. Almost half the patients surveyed in a Malaysian rheumatology 
clinic had no knowledge of NSAID side effects, while patients in a Danish rheumatology clinic 
showed lack of awareness of underlying factors which can increase risks of side effects [6]. 
However we found no studies exploring knowledge of NSAID risks among orthopaedic patients.  
Previous studies from several countries also suggest frequent inappropriate use of over the counter 
NSAIDs, as well as poor knowledge of risks associated with these agents [4, 8, 12]. One such 
study, conducted in Thailand, found that NSAID use was inversely related to knowledge about 
NSAIDs but positively associated with obtaining analgesics from community pharmacies [12]. 
NSAID use in Thailand is associated with adverse events, as elsewhere. A retrospective study 
involving 12,591 NSAID prescriptions from 1,030 patients found a total of 78 gastrointestinal 
events and 49 cardiovascular events [13]. Over the period 1984-2014, analgesic drugs, particularly 
NSAIDs, were the second most frequently cited drugs in spontaneous adverse drug reaction (ADR) 
reports in Thailand [14]. Meanwhile, only  gastrointestinal side effects were often concerned and 
identified by patients, but other complications were less concerned [5, 15].  
Awareness of the potential side effects of NSAIDs and factors increasing their risk is 
important, to ensure that patients achieve optimum benefit with minimal adverse events. The 
provision of information is thus key when prescribing and supplying these drugs. In many 
countries, written information is provided with all medicines, but some studies suggest that this 
does not necessarily translate into increased awareness of potential risks [16, 17]. For many people, 
health professionals are the main source of information about medicines [18-23], particularly in 
countries where written information is less freely available, such as Thailand [24]. We have 
previously shown that pharmacists and physicians play a major role in providing medicines safety 
information to Thai patients prescribed NSAIDs [25]. However, relatively little is known about 
Thai patients’ perceptions and knowledge of NSAID risks. 
Aims of the study 
In this study, we aim to determine patients’ perceptions and knowledge of the risks of NSAIDs 
and factors affecting them. 
Ethical approval 
The study was approved by the Ethics Committee for Human research, Khon Kaen University. 
Reference number HE551130. 
Methods 
Study design and setting  
This cross-sectional study was conducted in an 800-bed university hospital, Khon Kaen, Thailand 
between February 2013 and May 2013. It involved patients visiting out-patient orthopaedic clinics 
during the study period, and using prescribed NSAIDs for at least one month. A systematic random 
sampling method was used to select the patients, excluding patients below 18 years of age, those 
unable to complete the questionnaire themselves or without support to complete it.  
Questionnaire development 
The questionnaire, described in more detail elsewhere [25],  included demographic questions and 
source of information about NSAIDs and experiences of ADRs from NSAIDs, as well as 
knowledge and perception of NSAID risks. Risk perceptions were measured using five questions 
each representing an associated risk from NSAIDs: gastrointestinal system, cardiovascular system, 
renal system, blood pressure, and respiratory system. For each, a 100-mm Visual Analogue Scale 
(VAS) was used to measure the perception of NSAID risk, ranging from "0" (no risk) to "10" 
(maximum risk). Patients indicated their perception by making “X” on the 100-mm VAS line. 
Patients' knowledge of factors which could increase the risk of adverse events from NSAIDs was 
measured using a list of 11 factors which did or did not have the potential to increase risk, each 
with three possible answers, "Yes", "No", or "Not sure". The questionnaire’s validity was assessed 
by three experts, using the index of consistency (IOC), which was 0.97 before and 0.99 after minor 
revision. Pilot testing was conducted, involving 20 orthopaedic patients, to ensure readability and 
ease of use before data collection started. 
Data collection 
Every fourth patient waiting for an appointment in the out-patient clinic was approached to take 
part by the pharmacist researcher. Patients were asked about history of NSAID use and their 
medical records were accessed to confirm this. Those who had received a prescription for an 
NSAID for at least one month were asked to participate in the study and a questionnaire with 
information sheet explaining the purpose of the study was then given to patients who agreed. A 
total of 500 self-administered questionnaires were distributed by hand and returned directly to the 
researcher the same day.  
Statistical analysis 
Data from completed questionnaires were analysed using IBM SPSS for Windows (version 19.0). 
Baseline characteristics of patients were presented by means with standard deviation (mean ± SD), 
or median with interquartile range (IQR) for continuous variables, and frequency and percentage 
for categorical variables. The perception scores were obtained by measuring the distance on the 
VAS line from “0” with the score ranging from 0 to 10 and are reported as mean ± SD. To assess 
knowledge of risk factors, the score for each of the 11 questions was counted, with each correct 
response being given a value of one and both "no" or "not sure" being given a value of zero. The 
total knowledge score range was thus 0-11 points, which was then categorised into two groups 
based simply on the proportion of correctly identified risk factors: low-level (correct answer ≤ 
50%, or answering 1-5 questions correctly) and high-level (correct answer > 50%, or answering 
>5 questions correctly). The chi-square test and independent t-test were used to determine 
associations for categorical data and continuous data, respectively. All the independent variables 
for which an association was found were entered into a regression model. Binary logistic 
regression was used to assess factors influencing patients' knowledge of risk factors. Multiple 
linear regression was used to assess factors influencing patients' perceptions of NSAID risks. 
Results 
Response rate and demographic details  
From the total 500 distributed questionnaires, 484 (96.8%) were returned, with 474 being fully 
completed (94.8%). The majority of respondents were female (N=337, 71.1%), more than half 
were educated to a low level (N=278, 59.5%), and the majority used an NSAID continuously or 
regularly (N=330, 69.6%) rather than intermittently or as needed. There were 107 (22.6%) with 
underlying cardiovascular disease, 56 (11.8%) with gastrointestinal disease and 37 (7.8%) with 
respiratory disease. Over half (N=270; 57.0%) were using a gastrointestinal medicine, 40 (8.4%) 
a cardiovascular medicine and 8 (1.7%) a respiratory medicine. The median number of comorbid 
diseases present was 1 (interquartile range (IQR) 0.0-1.0) and median number of concomitant 
medicines used was 2 (IQR 2.0-4.0). Overall, only 256 (47.1%) claimed to have received any 
information about NSAID side effects. 
Experiences of adverse events 
Seventy-eight (16.5%) respondents indicated that they had experienced at least one ADR from a 
NSAID. Patients who had experienced an ADR had more underlying diseases (1.35 ± 1.17) than 
those who had no ADR (0.74 ± 0.91) (P<0.001). Moreover, the occurrence of ADRs was 
significantly higher in patients who reported regular NSAID use (20.6%) than in patients using 
them intermittently (6.9%). Those reporting an ADR also reported shorter overall duration of 
NSAID use (3.1±3.4 months) compared to those with no ADR (4.1±5.5 months). 
Perceptions of NSAID risks 
None of the five categories of risk achieved an average scores above 5 on the VAS, indicating 
overall low perceptions of risk relating to NSAIDs. Patients perceived risks from NSAIDs to the 
renal system to be highest (mean±SD: median (IQR), 3.80±2.97: 4.10 (0.0-5.8)), followed by 
gastrointestinal system (2.93±2.92: 2.40 (0.0-4.9)), however, blood pressure (0.82±1.84: 0.00 (0.0-
1.1)), cardiovascular system (0.00 (0.0-0.5)) and respiratory system (0.48±1.54: 0.00 (0.0-0.0)) 
were perceived to be very low to no risk. There was a statistically significant difference in 
perceived risk level to the gastrointestinal system among users of non-selective and selective 
NSAIDs (3.47±2.75 vs 2.06±2.98, P<0.001), but nor for other risks (Figure 1). However, there 
were no differences in perceived risk level between patients with or without experience of ADRs 
from NSAIDs. 
 (Insert Figure 1) 
Multiple linear regression was used to identify the factors affecting NSAID risk perception, 
but had low predictive power, being highest (19%) for gastrointestinal risks. Regarding overall 
NSAID risk perception, younger patients and those who received side effect information tended 
to have higher perception of risk (Table 1). In relation to individual risks, older patients and 
selective NSAID users perceived gastrointestinal risks to be lower, whereas those who had 
received information about side effects or had experienced an ADR perceived risk as higher. 
Educational level affected perceptions of cardiovascular and respiratory risks, while receipt of 
information about side effects also influenced perceptions of the risk of increased blood pressure 
and renal problems, but not cardiovascular risk. 
(Insert Table 1) 
Knowledge of risk factors for adverse events 
Overall awareness of factors which may increase the risks of adverse events from NSAIDs is 
shown in Table 2. Almost 80% knew that long-term therapy (N=140, 75.3%), using a high dose 
(N=151, 81.2%), having underlying gastrointestinal problems (N=143, 76.9%) and renal disease 
(N=149, 80.1%) could increase the risk of adverse events. However, only around half thought the 
elderly had an increased risk (N=98, 52.7%) or that use of multiple NSAIDs was a risk factor 
(N=93, 50.0%).  There was, however, much uncertainty in particular about whether anticoagulant 
use (N=158, 84.9%), smoking (N=104, 55.9%), hypertension (N=100, 53.8%) and cardiovascular 
disease (N=97, 52.2%) presented additional risk. 
(Insert Table 2) 
The mean score for all 474 patients was 5.13+2.65. From logistic regression, patients with 
high-level knowledge scores were more likely to have underlying disease (adjusted odds ratio; 
ORadj 1.64, 95%CI 1.01-2.44), and to have received side effect information (ORadj 2.02, 95%CI 
1.35-3.03), than those with low-level knowledge scores. 
 (Insert Table 3) 
Discussion 
Overall perceptions of potential risks from NSAIDs were low among this population of Thai 
NSAID users, with the highest perceived risk being for gastrointestinal problems, in particular 
among those using non-selective NSAIDs. There may be several reasons for these findings. First, 
non-selective NSAIDs have been available for much longer than selective agents, thus patients 
may have had more opportunity to receive information about their risks. This is supported by our 
previous study [25], which showed that users of selective NSAIDs were less likely to receive side 
effect information than users of non-selective NSAID. Second, the gastro-intestinal effects of non-
selective NSAIDs are widely known, , hence patients may have experienced these ADRs thus may 
perceive this particular risk more than others. Third, healthcare professionals may be more likely 
to inform patients about gastrointestinal risks from NSAIDs than other risks. Previous experience 
of an ADR from an NSAID and educational level were related to perceptions of risk, as was receipt 
of information about side effects, but this varied for different risks. Knowledge of factors with 
potential to increase risk was also lower than desirable, but higher among those who had received 
some information about side effects. 
Previous work in the Slovak Republic has shown low perceptions of NSAID risk among 
hospital in-patients, using a similar VAS score, with risk perceived as between 3.8 and 4.7 [9]. 
Thus our study suggests that Thai patients perceive risk to be lower. Other work shows that patients 
generally perceive NSAIDs as having lower levels of risk than healthcare professional [26, 27]. 
Studies suggest that 56% of patients prescribed NSAIDs believe them to be safe for use [4], but 
that gastrointestinal problems are the most frequently cited potential side effects followed by 
kidney disease [10], similar to our findings. Provision of information about NSAID risks by 
physicians has been shown to be positively associated with awareness of NSAID risk among 
patients [7, 10]. Only around half of the patients in our study had received any information about 
potential side effects, whether from physicians or pharmacists. This appeared to increased risk 
perception in relation to gastrointestinal system, renal system and blood pressure, but not 
cardiovascular or respiratory conditions. Older age and lower educational level were also potential 
factors influencing perceptions, and have been shown elsewhere to influence risk awareness [12, 
16, 28]. Awareness of underlying problems which can contribute to or increase risks from NSAIDs 
is important in ensuring that patients inform health professionals about these when NSAIDs are 
being prescribed, which may not always be the case [29]. Perhaps most important is the need to 
inform health professionals, whether physicians or community pharmacists, of existing NSAID 
use, to reduce the risk of multiple prescription. Only half the patients in our study were aware that 
using multiple NSAIDs increased risk of ADRs, with 45% being uncertain. Studies suggest that 
multiple NSAID use is not infrequent among the general public in other countries [3, 4, 8], 
however the only study on NSAID use in Thailand reported to date failed to determine whether 
multiple NSAIDs were used [12]. 
Strengths and limitations 
In this study, we used the VAS approach to measuring risk perception has been used previously, 
enabling comparison with other work. Moreover, our study achieved a high response rate, most 
likely because a systematic sampling approach was used to recruit patients, as well as the 
questionnaires being directly distributed to patients. However, the sample size was small, and it 
involved orthopaedic outpatients in only one university hospital and did not involve people using 
over the counter NSAIDs. Furthermore, a large proportion of respondents were female, hence the 
results may not be representative of the wider Thai population. Recall bias may also have occurred, 
particularly for patients who had been taking NSAIDs long-term. 
Conclusion 
Both perception of risk and knowledge of risk factors for NSAID use were very low in Thai 
patients. More frequent provision of side effect information could lead to better risk perception 
and knowledge about NSAIDs, especially among those of older age and low education level. 
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Appendix 
Table 1 Factors associated with patients’ perception on NSAID risks (Linear regression analysis) 
Factors b SEb  t 
95% Confidence Interval 
p-value 
Lower Upper 
Risks to the gastrointestinal system a       
Age -0.49 0.18 -0.11 -2.68 -0.85 -0.13 0.008 
Group of NSAID used -0.95 0.26 -0.16 -3.69 -1.45 -0.44 <0.001 
Receive side effect information  1.93 0.26 0.32  7.42  1.43  2.44 <0.001 
ADR experience  0.95 0.33 0.12  2.88  0.30  1.59 0.004 
 Constant 2.98; SEest= ±2.63 
 R = 0.44; Adjusted R2 = 0.19; F=28.27; p-value= <0.001 
Risks to the cardiovascular system b       
Educational level 0.46 0.17 0.13 2.73 0.13 0.79 0.007 
Receive side effect information 0.23 0.17 0.06 1.33 -0.11 0.56 NS 
 Constant 0.46; SEest= ±1.71 
 R = 0.14; Adjusted R2 = 0.02; F=5.01; p-value= 0.007 
Risks to the renal system c        
Gender 0.60 0.30 0.09 2.02 0.02 1.19 0.04 
Receive side effect information 1.09 0.28 0.18 3.87 0.53 1.63 <0.001 
Regularity of NSAIDs use 0.30 0.30 0.05 1.02 -0.28 0.89 NS 
 Constant 2.87; SEest= ±2.91 
 R = 0.21; Adjusted R2 = 0.04; F=6.87; p-value= <0.001 
Risk to blood pressure d        
Receive side effect information 0.52 0.17 0.14 2.99 0.18 0.86   0.003 
ADR experience 0.29 0.23 0.06 1.28 -0.16 0.75   NS 
 Constant 0.57; SEest= ±1.816 
 R = 0.146; Adjusted R2 = 0.017; F=5.050; p-value= 0.007 
Risks to the respiratory system e        
Gender 0.33 0.16 0.10 2.02 0.01 0.65 0.04 
Age -0.14 0.11 -0.06 -1.24 -0.36 0.08 NS 
Educational level 0.33 0.16 0.10 2.09 0.02 0.64 0.03 
Receive side effect information 0.23 0.15 0.07 1.55 -0.06 0.53 NS 
 Constant 0.22; SEest= ±1.54 
 R = 0.17; Adjusted R2 = 0.02; F=3.47; p-value= 0.008 
Overall NSAID risk perception        
Age -1.046 .518 -.094 -2.021 -2.064 -.029 0.044 
Receive side effect information 4.281 .719 .277 5.951 2.867 5.695 <0.001 
 Constant 8.475; SEest= ±7.16 
 R = 0.096; Adjusted R2 = 0.092; F=23.104; p-value<0.001 
 
Notes: 
b      denotes the variable estimate 
SEb  denotes the standard error of the variable estimate 
     denotes the standardized estimate 
t     denotes the t-value 
NS  denotes non-significant 
a Adjusted for age, health insurance, herb/supplement, group of NSAIDs, concomitant drugs, comorbid 
diseases, duration of use, regularity of  NSAID use, receive side effect information, and ADR 
experience 
b Adjusted for age, educational  level, occupation, income, receive side effect information, and ADR 
experience 
c Adjusted for gender, regularity of  NSAID use, receive side effect information, and ADR experience 
d Adjusted for age, educational level, concomitant drugs, regularity of  NSAID use, receive side effect 
information, and ADR experience 
e Adjusted for gender, age, educational level, income, herb/supplement, regularity of  NSAID use, 














Table 2 Patients' knowledge concerning risk factors of NSAIDs 
Potential risk factors for NSAID-related ADRs 
Number of patients (%) 
Know Not know Not sure 
Using a high dose of NSAIDs 151 (81.2) 6 (3.2) 29 (15.6) 
Using NSAIDs in patient with renal disease 149 (80.1) 5 (2.7) 32 (17.2) 
Using NSAIDs in patient with gastrointestinal ulcer or bleeding 
history 
143 (76.9) 2 (1.1) 41 (22.0) 
Long-term use of NSAIDs 140 (75.3) 6 (3.2) 40 (21.5) 
Using NSAIDs in elderly 98 (52.7) 6 (3.2) 82 (44.1) 
Multiple NSAIDs use 93 (50.0) 9 (4.8) 84 (45.2) 
Drinking alcohol during NSAIDs therapy 86 (46.2) 11 (5.9) 89 (47.8) 
Using NSAIDs in patient with cardiovascular disease  72 (38.7) 17 (9.1) 97 (52.2) 
Using NSAIDs in patient with hypertension 63 (33.9) 23 (12.4) 100 (53.8) 
Smoking during NSAIDs therapy 48 (25.8) 34 (18.3) 104 (55.9) 










Table 3 Factors associated with patients’ knowledge on NSAID risk factors (Logistic regression 
analysis)a 
 Factors 




95% C.I.  
p-value 
≤ 50% of all > 50% of all Lower Upper 
Underlying diseases       
Not have 133 (51.6) 95 (44.0) 1    
Have 125 (48.4) 121 (56.0) 1.64 1.10 2.44 0.02 
Receive side effect information       
No 176 (68.2) 112 (51.9) 1    
Yes 82 (31.8) 104 (48.1) 2.02 1.35 3.03 0.001 
Concomitant drugs (Mean ± S.D.) 2.91±1.75 2.65±1.68 0.89 0.78 1.00 NS 
Notes: 
NS  denotes not significant 
a Variables included in the analysis were education level, occupations, income, underlying disease, 
concomitant drugs, duration of use, regularity of NSAID use, receive side effect information, and 
ADR experience 









Figure 1 Mean (± S.D.) visual analog scale of perception on NSAID risks classified by type 
of NSAIDs 
 
 
